Company Active LTD

Company profile

Ncimb Limited

NCIMB | Microbiology | Analytical Services | Biomaterial Storage

Ncimb Limited is a UK company with status active founded in 1982 based in Scotland.

CRN
SC078368
Founded
1982
Age
44

Overview

Legal name
NCIMB LIMITED
Region
Scotland
Registered address
WELLHEADS PLACE
DYCE
ABERDEEN
SCOTLAND
AB21 7GB
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

23 events
19 Sep
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Jul
2026

Accounts due

Accounts Due

Next accounts due date

05 Sep
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

06 Sep
2024

Second Filing Of Confirmation Statement With Made Up Date

Confirmation-statement

RP04CS01 | Transaction MzQzNDc1NzQ1N2FkaXF6a2N4

Published 06 Sep 2024 09:17

05 Sep
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQzNDYyNzI5OGFkaXF6a2N4

Published 05 Sep 2024 10:49

31 Jul
2024

Accounts filed

Accounts

Last accounts made up date

14 Sep
2022

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzM1MTg3MDYxNWFkaXF6a2N4 | Paper/PDF filed

Published 06 Sep 2024 09:16

24 Mar
1994

Legacy

Annual-return

363S | Transaction MTMwODA2MDQ0YWRpcXprY3g

Published 12 Sep 2024 06:16

19 Nov
1993

Accounts With Accounts Type Full

Accounts Analysed

AA | Transaction NDkwMjEzNzNhZGlxemtjeA

Published 12 Sep 2024 05:58

27 May
1993

Accounts With Accounts Type Full

Accounts Analysed

AA | Transaction MTE0MzAyOTAwYWRpcXprY3g

Published 12 Sep 2024 05:58

16 Sep
1992

Accounts With Accounts Type Full

Accounts Analysed

AA | Transaction MTIxNzYwMzE0YWRpcXprY3g

Published 12 Sep 2024 06:07

08 Sep
1992

Legacy

Accounts Analysed

225(1) | Transaction MTQ3NzM4NDU1YWRpcXprY3g

Published 12 Sep 2024 05:58

18 Sep
1991

Legacy

Annual-return

363A | Transaction ODQxNDYwNzBhZGlxemtjeA

Published 12 Sep 2024 05:59

09 Sep
1991

Accounts With Accounts Type Full

Accounts Analysed

AA | Transaction MTMzMDc3NzgzYWRpcXprY3g

Published 12 Sep 2024 05:58

27 Nov
1990

Legacy

Annual-return

363 | Transaction MTE5MTkxMDUyYWRpcXprY3g

Published 12 Sep 2024 05:59

20 Nov
1990

Accounts With Accounts Type Full

Accounts Analysed

AA | Transaction MzYxMDkwMjNhZGlxemtjeA

Published 12 Sep 2024 05:58

01 Nov
1989

Accounts With Accounts Type Full

Accounts Analysed

AA | Transaction OTc3MzI2NDRhZGlxemtjeA

Published 12 Sep 2024 05:58

01 Nov
1989

Legacy

Annual-return

363 | Transaction MTQ5MTg5NDE5YWRpcXprY3g

Published 12 Sep 2024 05:58

07 Oct
1988

Legacy

Annual-return

363 | Transaction MTE2MzUxMzA5YWRpcXprY3g

Published 12 Sep 2024 06:06

07 Oct
1988

Accounts With Accounts Type Full

Accounts Analysed

AA | Transaction MTE2MDE2MTY3YWRpcXprY3g

Published 12 Sep 2024 05:59

21 Dec
1987

Legacy

Annual-return

363 | Transaction Nzc3NjI2MjVhZGlxemtjeA

Published 12 Sep 2024 05:59

15 Dec
1986

Legacy

Annual-return

363 | Transaction MTA4Njc5ODgwYWRpcXprY3g

Published 12 Sep 2024 06:07

20 Apr
1982

Incorporated

Inception

Company registered at Companies House

Public funding

9 awards
First funded
2012
Funded years
2012, 2013, 2014, 2016, 2024
Age at first award
30 years

Projects

2024 Collaborative R&D Lead participant

Superior synbiotics for healthy ageing

1 Oct 2024 to 31 Mar 2026

Awarded
£87,556
Total cost £125,080

Scottish biotechnology company NCIMB, is teaming up with the Rowett Institute, University of Aberdeen to develop novel designer probiotics targeting gut health. NCIMB are microbiology experts and manage the UK's largest collection of bacterial strains. The Rowett Institute has expertise in the gut microbiome and the interactions between microbes and inter...

2024 Launchpad Lead participant

Development and Manufacture of Novel Cyclodextrins

1 May 2024 to 30 Apr 2025

Awarded
£99,763
Total cost £99,763

Cyclodextrins are cyclic oligosaccharides produced from starch hydrolysis using bacterial enzymes. They are safe, natural products that trap, solubilise, and stabilise a range of bioactive molecules. They are highly selective with applications in food, food supplements, personal care, pharmaceuticals, agrochemicals, paints, and surface coatings. The marke...

2024 Collaborative R&D Lead participant

Harnessing the power of engineering biology to develop and translate novel live biotherapeutics

1 Feb 2024 to 31 Jan 2025

Awarded
£136,662
Total cost £195,231

In this exciting collaborative project, NCIMB, an established Scottish biotechnology company, is teaming up with GitLife Biotech (GLB), a spinout from Newcastle University. The partners aim to develop new innovative products and services using groundbreaking Engineering Biology protocols. The proposed project centres around the development of a new class ...

2016 Feasibility Studies Lead participant

Neutralising the harmful effects of dental biofilms by bacterial replacement therapy

1 Jun 2016 to 31 May 2017

Awarded
£48,926
Total cost £69,894

Dental caries is a widespread oral disease that is costly for health services to treat, and causes pain and loss of teeth to those affected. It is caused by production of acid by oral bacteria in biofilms on the teeth and gums commonly known as dental plaque. Brushing teeth can reduce this problem, but many people do not do so regularly or thoroughly. Thi...

2016 Feasibility Studies Lead participant

Management and control of biofilms in the oil and gas industry

1 Mar 2016 to 28 Feb 2017

Awarded
£59,623
Total cost £85,176

Microbial biofilms can cause significant economic and environmental issues in oilfield systems from reduction in flow rates, souring of crude oil and contribution to corrosion of concrete and metal surfaces. Current methods for the control of biofilms in these situations include the use of chemical biocides which are expensive and can lead to environmenta...

2016 Knowledge Transfer Partnership

The Robert Gordon University and NCIMB Limited

1 Jan 2016 to 31 Dec 2018

Awarded
Unknown

To initiate exploitation of the NCIMB culture collection by developing knowledge and processes for screening Streptomyces sp. for novel natural commercial products and the development of new product lines.

2014 Feasibility Studies Lead participant

Identification of novel probiotic microorganisms for improved gut function

1 Jan 2014 to 31 Dec 2014

Awarded
£52,295
Total cost £69,727

Probiotics are live microorganisms which when taken in adequate amounts confer health benefits. Changing diets and lifestyles have seen an increase in diet-related health conditions which probiotics acting as novel functional food ingredients can help. There are many probiotic species but the majority of commercial products are restricted to the Lactobaci...

2013 Feasibility Studies Lead participant

Optimising energy production from anaerobic digestion using molecular microbial monitoring techniques developed for the oil and gas industries

1 Mar 2013 to 30 Jun 2013

Awarded
£12,764
Total cost £17,019

This feasibility study will investigate the potential of transferring competency and methods developed for use in the oil industry for the determination of bacterial populations, to the production of renewable energy from wastes and other renewable sources using anaerobic digestion (AD) technology. Improved performance and lowering of associated risks in ...

2012 Collaborative R&D

Accelerated development of industrial microbes using GSA

1 Sep 2012 to 31 Aug 2014

Awarded
£139,336
Total cost £278,672

This project addresses a severe limitation of the critical enabling technology required for the successful industrial use of engineered microbes, namely to rapidly achieve efficient production of proteins from heterologous DNA, either as end products in themselves or as enzymes whose concerted action produces other high value products. The project follows...

Product types

Collaborative R&D Feasibility Studies Knowledge Transfer Partnership Launchpad